We have previously shown that peripheral human TNF-α and anti-TNF-α therapy, currently used in RA treatment, play a significant role in modulating neuroinflammation, amyloid deposition and neuronal degeneration in AD mice21,22. This evidence concerns the gene TNF and rheumatoid arthritis.